Search results
Results from the WOW.Com Content Network
E. W. Kemble's "Death's Laboratory" on the cover of Collier's (June 3, 1905). A patent medicine, also known as a proprietary medicine or a nostrum (from the Latin nostrum remedium, or "our remedy") is a commercial product advertised to consumers as an over-the-counter medicine, generally for a variety of ailments, without regard to its actual effectiveness or the potential for harmful side ...
Wikipedia entry for Google Patents.Google Patents is a search engine from Google that indexes patents and patent applications from the United States Patent and Trademark Office.
These patents have been broadly licensed and have been the subject of litigation among patent holders and companies that have brought monoclonal antibody drugs to market. [25] A patent application for the isolated BRCA1 gene and cancer-promoting mutations, as well as methods to diagnose the likelihood of getting breast cancer, was filed by the ...
Pharmaceutical innovations are currently guided by a patent system, [1] the patent system protects the innovator of medicines for a period of time. The patent system does not currently stimulate innovation or pricing that provides access to medicine for those who need it the most, It provides for profitable innovation. [2]
State-of-the-Art Transdermal Drug Delivery Patents From Vyteris to be Sold via Global Online Sale by Heritage Global Partners June 27-28 SAN DIEGO & FOSTER CITY, Calif.--(BUSINESS WIRE)-- Heritage ...
A particularly difficult question of value arises where inventors/owners use their patents to extract other advantages without actually marketing the invention (e.g., cross-licensing of related patents to avoid litigation, or suppressing a technology that could compete with the owner's other products). [22]
Senator Bernie Sanders of Vermont put forward legislation in the United States Senate in 2005 and 2007 under H.R. 417 and S.2210. [4] Sanders has been a longtime proponent of Stiglitz’ ideas, and favors a system of incentives for innovation in medicine and pharmaceuticals over a system of patents, which he asserts grant company monopolies on drugs and drive up pharmaceutical prices.
A U.S. Patent Office tribunal on Monday rejected challenges to two key patents owned by Novo Nordisk covering the active ingredient in its weight-loss and diabetes drugs Wegovy and Ozempic brought ...